RNS Number : 4548Z
Location Sciences Group PLC
21 May 2021
 

 

 

21 May 2021

 

Location Sciences Group PLC
("Location Sciences" or the "Company")

 

Result of General Meeting, Issue of Equity and Total Voting Rights

 

 

 

Result of General Meeting

 

The Company is pleased to announce that at its General Meeting held earlier today in connection with the proposed fundraise and Board changes announced on 4 May 2021, all Resolutions were put to the meeting and were duly passed. The voting results from the General Meeting are included at the end of this announcement.

 

Issue of new Ordinary Shares in consideration for cancellation of warrants

 

The Company announces that it has also agreed with the existing warrant holder in the Company to surrender all warrants over Ordinary Shares issued pursuant to the warrant instrument dated 12 December 2016, in consideration for the issue and allotment of 5,000,000 new Ordinary Shares at 0.2 pence per new Ordinary Share in the Company (the "Warrant Cancellation Shares"). The Warrant Cancellation Shares will be issued utilising the Company's existing share authorities put in place at the Company's annual general meeting held on 9 April 2020 and by way of a subscription with the Company.

 

Admission of New Ordinary Shares

 

Application has been made to the London Stock Exchange for 2,017,750,000 new Ordinary Shares, which comprises the Placing Shares, the Subscription Shares, the Fees Shares (excluding 42,500,000 Fees Shares in respect of the second year's fees of the Proposed Directors), the Broker Option Shares and the Warrant Cancellation Shares, to be admitted to trading on AIM. It is anticipated that Admission will occur and that dealings will commence in the New Ordinary Shares at 8.00 a.m. on 25 May 2021.

 

Total Voting Rights

 

Following Admission, the Company will have 2,605,087,398 Ordinary Shares in issue. The Company holds no shares in treasury. Therefore, the Company hereby confirms that the total number of voting rights in the Company will, following Admission, be 2,605,087,398.

 

Shareholders may use this figure of 2,605,087,398 as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

A separate announcement will be made relating to the planned Board changes which will become effective immediately following Admission.

 

A copy of this announcement is available on the Company's website https://www.locationsciencesgroup.ai/investor-relations/rns-news-alerts/.  

 

Terms defined in the circular to shareholders published by the Company on 4 May 2021 shall have the same meanings when used in this announcement.

 

 

For further information please contact:

 

Location Sciences Group PLC                                                                                                         via Milk & Honey PR

Mark Slade, Chief Executive Officer

David Rae, CFO and Commercial Director

 

Allenby Capital Limited (Nominated Adviser)                                                                     Tel: +44 (0)20 3328 5656

David Hart

David Worlidge

 

Turner Pope Investments (TPI) Ltd (Placing Agent)                                                              Tel: +44 (0)20 3657 0050

James Pope

Andy Thacker

 

Peterhouse Capital (Broker)                                                                                                   Tel: +44 (0) 20 7220 9791

Charles Goodfellow

Eran Zucker

 

Milk & Honey PR                                                                                                                         Tel: +44 (0)20 3637 7310

Kirsty Leighton

Jessica Ballinger

 

 

 

 

No.

Resolution

 

For*

Against

1

To approve the waiver granted by the Panel on Takeovers and Mergers described in the Circular.

91.2%

8.8%

2

To grant the Directors authority to allot equity securities in the Company in the amounts set out in the Notice of General Meeting.

91.2%

8.8%

3

To grant the Directors authority to allot equity securities in the Company for cash as if section 561 of the Act did not apply in the amounts set out in the Notice of General Meeting.

91.2%

8.8%

4

To elect Simon Wilkinson as a Director with effect from Admission.

95.6%

4.4%

5

To elect Dr Nigel Burton as a Director with effect from Admission.

95.6%

4.4%

 

* Includes proxies received to be voted at the discretion of the Chairman.

 

About Location Sciences Group PLC:

 

Location Sciences is the pre-eminent global location verification provider to the $160 billion digital advertising industry. Working in partnership with brands, media agencies and suppliers to reduce ad-wastage and improve the effectiveness of location-based advertising campaigns.

 

The digital advertising market-place remains unregulated and un-monitored, with an estimated $19 billion wasted on ad-fraud in 2018. Location Sciences has developed Verify, the world's first independent location verification product. Utilising sophisticated machine learning and pattern recognition technologies, Verify detects location ad-fraud and shines a light on location data inaccuracy with the aim of bringing back integrity, transparency and trust to the market place.

 

Rule 26 website:  www.locationsciencesgroup.ai

Verify website:     www.locationsciences.ai

LinkedIn:               https://www.linkedin.com/company/locationsciences

Twitter:                   @LocationSci

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMMZGZKGMFGMZM